489 related articles for article (PubMed ID: 17905482)
1. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern.
Letiembre M; Liu Y; Walter S; Hao W; Pfander T; Wrede A; Schulz-Schaeffer W; Fassbender K
Neurobiol Aging; 2009 May; 30(5):759-68. PubMed ID: 17905482
[TBL] [Abstract][Full Text] [Related]
2. Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases.
Ebert S; Goos M; Rollwagen L; Baake D; Zech WD; Esselmann H; Wiltfang J; Mollenhauer B; Schliebs R; Gerber J; Nau R
J Neurosci Res; 2010 Apr; 88(5):1124-36. PubMed ID: 19859962
[TBL] [Abstract][Full Text] [Related]
3. Innate immune receptor expression in normal brain aging.
Letiembre M; Hao W; Liu Y; Walter S; Mihaljevic I; Rivest S; Hartmann T; Fassbender K
Neuroscience; 2007 Apr; 146(1):248-54. PubMed ID: 17293054
[TBL] [Abstract][Full Text] [Related]
4. Immune blood biomarkers of Alzheimer disease patients.
Avagyan H; Goldenson B; Tse E; Masoumi A; Porter V; Wiedau-Pazos M; Sayre J; Ong R; Mahanian M; Koo P; Bae S; Micic M; Liu PT; Rosenthal MJ; Fiala M
J Neuroimmunol; 2009 May; 210(1-2):67-72. PubMed ID: 19329192
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.
Mariani E; Polidori MC; Cherubini A; Mecocci P
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):65-75. PubMed ID: 16183338
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of neurodegenerative disorders: how good are they?
Rachakonda V; Pan TH; LE WD
Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
[TBL] [Abstract][Full Text] [Related]
8. Transgenic animal models of neurodegenerative diseases and their application to treatment development.
Rockenstein E; Crews L; Masliah E
Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376
[TBL] [Abstract][Full Text] [Related]
9. [Conformationally altered proteins cause neurodegenerative diseases].
Ingelsson M; Nilsson L; Basun H; Aquilonius SM; Lannfelt L
Lakartidningen; 2005 Nov 21-27; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392
[TBL] [Abstract][Full Text] [Related]
10. Amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease: phylogenetic disorders of the human neocortex sharing many characteristics.
Eisen A; Calne D
Can J Neurol Sci; 1992 Feb; 19(1 Suppl):117-23. PubMed ID: 1571856
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice.
Frank S; Copanaki E; Burbach GJ; Müller UC; Deller T
Neurosci Lett; 2009 Mar; 453(1):41-4. PubMed ID: 19429012
[TBL] [Abstract][Full Text] [Related]
12. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
Gallardo G; Schlüter OM; Südhof TC
Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
[TBL] [Abstract][Full Text] [Related]
13. Maillard reaction versus other nonenzymatic modifications in neurodegenerative processes.
Pamplona R; Ilieva E; Ayala V; Bellmunt MJ; Cacabelos D; Dalfo E; Ferrer I; Portero-Otin M
Ann N Y Acad Sci; 2008 Apr; 1126():315-9. PubMed ID: 18079479
[TBL] [Abstract][Full Text] [Related]
14. CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease.
Noguchi-Shinohara M; Tokuda T; Yoshita M; Kasai T; Ono K; Nakagawa M; El-Agnaf OM; Yamada M
Brain Res; 2009 Jan; 1251():1-6. PubMed ID: 19071095
[TBL] [Abstract][Full Text] [Related]
15. Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions.
McGeer PL; McGeer EG
Alzheimer Dis Assoc Disord; 1998; 12 Suppl 2():S1-6. PubMed ID: 9769023
[TBL] [Abstract][Full Text] [Related]
16. The LPS receptor (CD14) links innate immunity with Alzheimer's disease.
Fassbender K; Walter S; Kühl S; Landmann R; Ishii K; Bertsch T; Stalder AK; Muehlhauser F; Liu Y; Ulmer AJ; Rivest S; Lentschat A; Gulbins E; Jucker M; Staufenbiel M; Brechtel K; Walter J; Multhaup G; Penke B; Adachi Y; Hartmann T; Beyreuther K
FASEB J; 2004 Jan; 18(1):203-5. PubMed ID: 14597556
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia.
Lehnardt S; Lehmann S; Kaul D; Tschimmel K; Hoffmann O; Cho S; Krueger C; Nitsch R; Meisel A; Weber JR
J Neuroimmunol; 2007 Oct; 190(1-2):28-33. PubMed ID: 17854911
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and neurodegeneration: the story 'retolled'.
Drouin-Ouellet J; Cicchetti F
Trends Pharmacol Sci; 2012 Oct; 33(10):542-51. PubMed ID: 22944460
[TBL] [Abstract][Full Text] [Related]
19. In vivo morphological changes in animal models of amyotrophic lateral sclerosis and Alzheimer's-like disease: MRI approach.
Andjus PR; Bataveljić D; Vanhoutte G; Mitrecic D; Pizzolante F; Djogo N; Nicaise C; Gankam Kengne F; Gangitano C; Michetti F; van der Linden A; Pochet R; Bacić G
Anat Rec (Hoboken); 2009 Dec; 292(12):1882-92. PubMed ID: 19943341
[TBL] [Abstract][Full Text] [Related]
20. What transgenic mice tell us about neurodegenerative disease.
Gurney ME
Bioessays; 2000 Mar; 22(3):297-304. PubMed ID: 10684590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
